D de Zeeuw Selected Research

D de Zeeuw Research Topics

Disease

15	Type 2 Diabetes Mellitus (MODY) 01/2016 - 12/2000
10	Chronic Kidney Failure (Chronic Renal Failure) 01/2016 - 12/2000
9	Proteinuria 10/2005 - 05/2000
8	Albuminuria 02/2016 - 07/2000
5	Heart Failure 10/2001 - 03/2000
2	Body Weight (Weight, Body) 01/2016 - 09/2013
2	Hypertension (High Blood Pressure) 09/2001 - 06/2001
1	Infections 01/2016
1	Diabetes Mellitus 05/2009
1	Renal Insufficiency (Renal Failure) 05/2009
1	Inflammation (Inflammations) 06/2008
1	Ischemia 06/2008
1	Acute Kidney Injury (Acute Renal Failure) 06/2008
1	Reperfusion Injury 06/2008
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 10/2005
1	Overweight 10/2004
1	Myocardial Infarction 08/2003
1	Kidney Diseases (Kidney Disease) 09/2001
1	Disease Progression 09/2001
1	Chronic Renal Insufficiency 07/2001
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2001
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 01/2001
1	Nephrosis 01/2001

Drug/Important Bio-Agent (IBA)

10	CreatinineIBA 01/2016 - 12/2000
9	Losartan (Cozaar)FDA LinkGeneric 02/2014 - 12/2000
8	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 02/2016 - 03/2000
8	AlbuminsIBA 01/2016 - 10/2000
7	Angiotensin Receptor AntagonistsIBA 02/2016 - 07/2000
5	Angiotensin IIIBA 02/2014 - 12/2000
4	SodiumIBA 01/2016 - 09/2001
4	Proteins (Proteins, Gene)FDA Link 09/2001 - 01/2001
2	aliskiren FDA Link 02/2016 - 04/2014
2	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2016 - 09/2013
2	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 09/2013
2	Biomarkers (Surrogate Marker)IBA 02/2013 - 05/2012
2	salicylhydroxamic acid (SHAM)IBA 05/2009 - 08/2003
2	Antihypertensive Agents (Antihypertensives)IBA 05/2006 - 12/2001
2	CholesterolIBA 07/2004 - 07/2000
2	Lisinopril (Prinivil)FDA LinkGeneric 01/2001 - 08/2000
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2016
1	CanagliflozinIBA 01/2016
1	SymportersIBA 01/2016
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2016
1	IncretinsIBA 01/2016
1	Histidine (L-Histidine)FDA Link 09/2014
1	dapagliflozinIBA 09/2013
1	DiureticsIBA 09/2013
1	Pharmaceutical PreparationsIBA 09/2013
1	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 09/2013
1	Peptides (Polypeptides)IBA 02/2013
1	PotassiumIBA 01/2011
1	Indicators and Reagents (Reagents)IBA 01/2011
1	CalciumIBA 01/2009
1	paricalcitol (Zemplar)FDA Link 01/2009
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2009
1	Parathyroid Hormone (Parathormone)IBA 01/2009
1	Interleukin-13 Receptors (Interleukin 13 Receptor)IBA 06/2008
1	Interleukin-13IBA 06/2008
1	Triglycerides (Triacylglycerol)IBA 07/2004
1	Insulin (Novolin)FDA Link 07/2004
1	HDL CholesterolIBA 07/2004
1	Metformin (Glucophage)FDA LinkGeneric 07/2004
1	AngiotensinsIBA 07/2001
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 04/2001
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 04/2001
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 01/2001
1	Proteoglycans (Proteoglycan)IBA 01/2001
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2001
1	Heparitin Sulfate (Heparan Sulfate)IBA 01/2001
1	zofenoprilIBA 08/2000
1	Acetylcysteine (Siran)FDA LinkGeneric 08/2000
1	Cholesterol Esters (Cholesteryl Esters)IBA 07/2000
1	LDL CholesterolIBA 07/2000
1	remikirenIBA 05/2000
1	ibopamineIBA 04/2000
1	Z1046IBA 04/2000
1	Dopamine Agonists (Dopamine Agonist)IBA 04/2000
1	Neurotransmitter Agents (Neurotransmitter)IBA 03/2000

Therapy/Procedure

5	Therapeutics 02/2016 - 05/2006
1	Nephrectomy 05/2009
1	Kidney Transplantation 06/2008
1	Ligation 08/2003
1	Surgical Amputation (Amputations) 12/2000